Literature DB >> 21880236

Diabetes and Technology for Increased Activity (DaTA) study: results of a remote monitoring intervention for prevention of metabolic syndrome.

Melanie Stuckey1, Elizabeth Russell-Minda, Emily Read, Claudio Munoz, Kevin Shoemaker, Peter Kleinstiver, Robert Petrella.   

Abstract

OBJECTIVE: An increasingly aged, overweight, and sedentary population has resulted in elevated risk of cardiovascular disease (CVD). The escalating incidence of diabetes and other chronic illnesses, deficits in health care budgets, and physician shortages, especially in rural communities, have prompted investigations of feasible solutions. The Diabetes and Technology for Increased Activity (DaTA) study was designed to test the effectiveness of a lifestyle intervention driven by self-monitoring of blood glucose (BG), blood pressure (BP), physical activity (PA), and weight to positively impact CVD risk factors in a medically underserviced rural population with a high incidence of metabolic syndrome (MS). RESEARCH DESIGN AND METHODS: Conducted in a community-based research setting, this single-center open feasibility study used smart phones to transmit BP, BG, pedometer, weight, heart rate, and activity measurements to a database. Technology allowed participants to interface with the clinical team and self-monitor their personal health indicators.
RESULTS: Twenty-four participants aged 30 to 71 years completed the 8-week intervention. Participants had significant improvement in clinic (p = .046) and self-monitored diastolic BP (p = .001), body mass index (p = .002), and total cholesterol (p = .009), and steps per day. Daily PA increased as well as participants' interest in and willingness to make lifestyle changes that impact health outcomes.
CONCLUSIONS: The DaTA study demonstrated that self-monitoring of the risk factors for MS and increased PA improved the participant's CVD risk profile. Considering the 8-week time period of this intervention, results are encouraging. This lifestyle intervention, which uses education and technology as tools, confirms the utility of remote health monitoring.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2011        PMID: 21880236      PMCID: PMC3192600          DOI: 10.1177/193229681100500416

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  24 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 3.  How many steps/day are enough? Preliminary pedometer indices for public health.

Authors:  Catrine Tudor-Locke; David R Bassett
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

5.  Self-efficacy and the stages of exercise behavior change.

Authors:  B H Marcus; V C Selby; R S Niaura; J S Rossi
Journal:  Res Q Exerc Sport       Date:  1992-03       Impact factor: 2.500

6.  Remote monitoring technologies for the prevention of metabolic syndrome: the Diabetes and Technology for Increased Activity (DaTA) study.

Authors:  Melanie Stuckey; Robyn Fulkerson; Emily Read; Elizabeth Russell-Minda; Claudio Munoz; Peter Kleinstiver; Robert Petrella
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

7.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

8.  Can primary care doctors prescribe exercise to improve fitness? The Step Test Exercise Prescription (STEP) project.

Authors:  Robert J Petrella; John J Koval; David A Cunningham; Donald H Paterson
Journal:  Am J Prev Med       Date:  2003-05       Impact factor: 5.043

9.  Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

10.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  18 in total

Review 1.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Authors:  Lora E Burke; Jun Ma; Kristen M J Azar; Gary G Bennett; Eric D Peterson; Yaguang Zheng; William Riley; Janna Stephens; Svati H Shah; Brian Suffoletto; Tanya N Turan; Bonnie Spring; Julia Steinberger; Charlene C Quinn
Journal:  Circulation       Date:  2015-08-13       Impact factor: 29.690

2.  Association between intensive health guidance focusing on eating quickly and metabolic syndrome in Japanese middle-aged citizens.

Authors:  Daisuke Ekuni; Michiko Furuta; Toshihide Kimura; Naoki Toyama; Daiki Fukuhara; Yoko Uchida; Nanami Sawada; Manabu Morita
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

3.  Remote monitoring technologies for the prevention of metabolic syndrome: the Diabetes and Technology for Increased Activity (DaTA) study.

Authors:  Melanie Stuckey; Robyn Fulkerson; Emily Read; Elizabeth Russell-Minda; Claudio Munoz; Peter Kleinstiver; Robert Petrella
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

Review 4.  Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis.

Authors:  R Jay Widmer; Nerissa M Collins; C Scott Collins; Colin P West; Lilach O Lerman; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2015-04       Impact factor: 7.616

5.  Exploring app features with outcomes in mHealth studies involving chronic respiratory diseases, diabetes, and hypertension: a targeted exploration of the literature.

Authors:  Sara Belle Donevant; Robin Dawson Estrada; Joan Marie Culley; Brian Habing; Swann Arp Adams
Journal:  J Am Med Inform Assoc       Date:  2018-10-01       Impact factor: 4.497

Review 6.  Measuring and influencing physical activity with smartphone technology: a systematic review.

Authors:  Judit Bort-Roig; Nicholas D Gilson; Anna Puig-Ribera; Ruth S Contreras; Stewart G Trost
Journal:  Sports Med       Date:  2014-05       Impact factor: 11.136

7.  Toward research-tested mobile health interventions to prevent diabetes and cardiovascular disease among persons with pre-diabetes.

Authors:  Steven S Coughlin; Jessica Lynn Stewart
Journal:  J Hosp Manag Health Policy       Date:  2017-11

Review 8.  Public health guidelines for physical activity: is there an app for that? A review of android and apple app stores.

Authors:  Emily Knight; Melanie I Stuckey; Harry Prapavessis; Robert J Petrella
Journal:  JMIR Mhealth Uhealth       Date:  2015-05-21       Impact factor: 4.773

9.  Diabetes and technology for increased activity study: the effects of exercise and technology on heart rate variability and metabolic syndrome risk factors.

Authors:  Melanie I Stuckey; Antti M Kiviniemi; Robert J Petrella
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-19       Impact factor: 5.555

Review 10.  Interactive telemedicine: effects on professional practice and health care outcomes.

Authors:  Gerd Flodgren; Antoine Rachas; Andrew J Farmer; Marco Inzitari; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.